(Q46873864)

26 December 2017

title

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation (English)

1 reference

26 December 2017

author

Francesc Moreso

5

1 reference

26 December 2017

author name string

Ibernón M

1

1 reference

26 December 2017

Gil-Vernet S

2

1 reference

26 December 2017

Carrera M

3

1 reference

26 December 2017

Serón D

4

1 reference

26 December 2017

Bestard O

6

1 reference

26 December 2017

Cruzado JM

7

1 reference

26 December 2017

Grinyó JM

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

26 December 2017

Transplantation Proceedings

published in

1 reference

26 December 2017

volume

37

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

3743-3745

1 reference

26 December 2017

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Rituximab as treatment for refractory kidney transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

The Banff 97 working classification of renal allograft pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.09.128

10.1016/J.TRANSPROCEED.2005.09.128

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017